KM-4056

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKM-4056
Drug Alias Nameanti-LGR5 monoclonal antibody (Kyowa Hakko Kirin)KM-4056
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionLeucine-rich repeat-containing G-protein coupled receptor 5 modulators
TargetsLeucine-rich repeat-containing G-protein coupled receptor 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Kirin Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A